Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac

Condition:   Tuberculosis Interventions:   Biological: GamTBvac;   Biological: Placebo Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials